Trial intelligence / Profile preview

Typhoid Vi Vaccine Effectiveness in Hechi, China

NCT00131833Phase 4Completed

Sponsor
International Vaccine Institute
Start
Oct 2001
Primary completion
Nov 2006
Modality
Split/Subunit Vaccines, Recombinant Protein Vaccines
Countries
1
01

Overview

A Phase 4 trial of salmonella typhi capsular polysaccharide vaccine in typhoid fever, paratyphoid fever, sponsored by International Vaccine Institute. Started Oct 2001; status: completed.

02

Drugs

salmonella typhi capsular polysaccharide vaccine
03

Conditions

typhoid feverparatyphoid fever

Beyond the preview

Go deeper on NCT00131833.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00131833.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call